Clinical trial
The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture
NCT00481585 · Hackensack Meridian Health, Other · Terminated
Key facts
| NCT number | NCT00481585 |
|---|---|
| Title | The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture |
| Official title | The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture |
| Lead sponsor | Hackensack Meridian Health, Other |
| Status | Terminated |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 13 |
| Start date | May 1, 2007 |
| Primary completion | Jul 1, 2009 |
| First posted | Jun 1, 2007 |
| Last update posted | Feb 4, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: